ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,341,000 | +28.4% | 115,289 | -32.4% | 0.04% | +26.5% |
Q1 2019 | $4,160,000 | +43.9% | 170,643 | -15.9% | 0.03% | +41.7% |
Q4 2018 | $2,891,000 | -17.0% | 202,847 | -11.5% | 0.02% | +4.3% |
Q3 2018 | $3,482,000 | +0.6% | 229,107 | +11.0% | 0.02% | 0.0% |
Q2 2018 | $3,462,000 | +2.5% | 206,364 | -0.3% | 0.02% | +187.5% |
Q1 2018 | $3,377,000 | +5.5% | 206,918 | -17.2% | 0.01% | 0.0% |
Q4 2017 | $3,200,000 | -12.3% | 250,014 | -15.7% | 0.01% | -11.1% |
Q3 2017 | $3,649,000 | +34.6% | 296,622 | -8.4% | 0.01% | +28.6% |
Q2 2017 | $2,712,000 | +18.8% | 323,966 | +26.8% | 0.01% | +16.7% |
Q1 2017 | $2,283,000 | -3.1% | 255,441 | -4.7% | 0.01% | -14.3% |
Q4 2016 | $2,357,000 | +4521.6% | 268,178 | +2099.1% | 0.01% | – |
Q4 2015 | $51,000 | -99.0% | 12,195 | -98.3% | 0.00% | -100.0% |
Q2 2015 | $5,033,000 | +241.7% | 698,115 | +249.2% | 0.01% | +300.0% |
Q1 2015 | $1,473,000 | +1890.5% | 199,904 | +1186.2% | 0.00% | – |
Q4 2014 | $74,000 | +4.2% | 15,542 | -22.5% | 0.00% | – |
Q3 2014 | $71,000 | -97.1% | 20,063 | -95.8% | 0.00% | -100.0% |
Q4 2013 | $2,418,000 | -9.3% | 482,613 | +12.6% | 0.01% | -30.0% |
Q3 2013 | $2,666,000 | – | 428,570 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |